Anavex Life Sciences Corp.
AVXL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001314052
No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Anavex Life Sciences Corp. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 169 | 1 | 181 | +13 |
| Shares | 29.6M | 179.0K | 31.4M | +1.97M (+6.7%) |
| Value | $316.5M | $1.92M | $269.2M | −$45.4M (−14.4%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (38)
Institutions that held Anavex Life Sciences Corp. at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (25)
Institutions that held Anavex Life Sciences Corp. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Sculptor Capital LP | 370,100 | $3.97M |
| Essential Planning, LLC. | 413,088 | $3.25M |
| Jump Financial, LLC | 153,231 | $1.65M |
| D. E. Shaw & Co., Inc. | 105,130 | $1.13M |
| Jane Street Group, LLC | 104,697 | $1.12M |
| Squarepoint Ops LLC | 67,627 | $726.3K |
| XTX Topco Ltd | 52,344 | $562.2K |
| Tudor Investment Corp Et Al | 46,044 | $494.5K |
| Atria Wealth Solutions, Inc. | 27,052 | $290.5K |
| Y-Intercept (Hong Kong) Ltd | 22,631 | $243.1K |
| Stratos Wealth Partners, LTD. | 22,457 | $241.2K |
| Fox Run Management, L.L.C. | 19,568 | $210.2K |
| Scientech Research LLC | 19,144 | $205.6K |
| Jain Global LLC | 18,799 | $201.9K |
| Fiduciary Alliance LLC | 11,048 | $118.7K |
| HSBC Holdings PLC | 10,347 | $110.3K |
| Prudential Financial Inc | 10,160 | $109.1K |
| Victory Capital Management Inc | 10,156 | $109.1K |
| Prosperity Financial Group, Inc. | 7,800 | $83.8K |
| Reyes Financial Architecture, Inc. | 2,490 | $26.7K |
| Kohmann Bosshard Financial Services, LLC | 1,500 | $16.1K |
| R Squared Ltd | 950 | $10.2K |
| Skopos Labs, Inc. | 816 | $8.76K |
| Richard W. Paul & Associates, LLC | 132 | $1.42K |
| Bay Harbor Wealth Management, LLC | 70 | $751 |
Not filed for Q1 2025 yet (1)
Institutions that held Anavex Life Sciences Corp. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 178,965 | $1.92M |